Joint Programming Initiative on Antimicrobial Resistance

The JPIAMR Strategic Research Agenda was finalised in December 2013 and launched in January 2014. Below are the key elements of the process:

  • A series of (5)Scientific Advisory Board (SAB) meetings (first one in 2011, one in 2012, three in 2013)
  • A consultation process with stakeholders:
    • Stakeholder Advisory Board meetings: Discussion of the SRA 1st draft in Brussels 18th April 2013 (more meetings are scheduled)
    • A stakeholders workshop: Geneva Invitation Conference 27th and 28th of May 2013 with members of  the   Management Board, Scientific Advisory Board, Stakeholder Advisory Board and 7 additional experts discussed a 2nd draft of the SRA
  • A series of expert workshops:
    • Preliminary workshops in 2012
    • Workshop on veterinarian perspective of AMR on 31st of July 2013
    • Brainstorming workshop with AMR experts at the July 2013 FEMS Conference in Berlin
  • An online public consultation process (September 1 – October 15 2013)
  • National consultations with input from all JPIAMR member states
  • The SRA was adopted by the JPIAMR Management Board in December 2013
  • The SRA was launched in January 2014

The JPIAMR Strategic Research and Innovation Agenda (SRIA) was updated in 2018 and is in the final stage of preparation. The key elements of the update process include:

  • Establishment of the Editorial Board and a series of Editorial Board meetings
  • SAB SRIA consultation meeting Amsterdam, December 2017
  • SAB feedback, January – May 2018
  • Consultation with the Innovative Medicines Initiative (IMI), June 2018
  • JPIAMR member country consultation, July-September 2018
  • Open consultation, July-September 2018
  • Management Board feedback session, October 2018
  • Collation of the SRIA, October-December 2018
  • SAB adoption of the SRIA, December 2018 – January 2019

Future steps in the SRIA update include:

  • Management Board adoption of the SRIA
  • Publication of the SRIA